S-531011

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameS-531011
Drug Alias NameS-531011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsC-C chemokine receptor type 8 inhibitorsRegulatory T-lymphocytes inhibitors
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShionogi Inc
China Registration ClassN/A

Develop Information

Active CompaniesShionogi IncShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A